These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 2449156)

  • 1. Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus.
    Auwerx J; Bouillon R; Collen D; Geboers J
    Arteriosclerosis; 1988; 8(1):68-72. PubMed ID: 2449156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinolysis system in patients with bronchial asthma.
    Banach-Wawrzeńczyk E; Dziedziczko A; Rość D
    Med Sci Monit; 2000; 6(1):103-7. PubMed ID: 11208294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tissue-type plasminogen activator and its inhibitor (PAI-1) in plasma in cases of non-insulin-dependent diabetes mellitus (NIDDM)].
    Jokaji H; Asakura H; Saito M; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Matsuda T
    Nihon Ronen Igakkai Zasshi; 1990 Nov; 27(6):699-705. PubMed ID: 2127812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between plasma insulin triglyceride, body mass index, and plasminogen activator inhibitor 1.
    Juhan-Vague I; Vague P; Alessi MC; Badier C; Valadier J; Aillaud MF; Atlan C
    Diabete Metab; 1987 Jul; 13(3 Pt 2):331-6. PubMed ID: 3115843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of tissue plasminogen activator activity by aspirin in vivo and its relationship to levels of tissue plasminogen activator inhibitor antigen, plasminogen activator and their complexes.
    Levin RI; Harpel PC; Harpel JG; Recht PA
    Blood; 1989 Oct; 74(5):1635-43. PubMed ID: 2529003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diurnal variation of the fibrinolytic system.
    Grimaudo V; Hauert J; Bachmann F; Kruithof EK
    Thromb Haemost; 1988 Jun; 59(3):495-9. PubMed ID: 3142085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects.
    Vague P; Juhan-Vague I; Aillaud MF; Badier C; Viard R; Alessi MC; Collen D
    Metabolism; 1986 Mar; 35(3):250-3. PubMed ID: 3081778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between smoking and fibrinolytic system with special reference to t-PA and PA inhibitor.
    Hashimoto Y; Kobayashi A; Yamazaki N; Takada Y; Takada A
    Thromb Res; 1988 Aug; 51(3):303-11. PubMed ID: 3140409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation and inhibition of fibrinolysis in septic patients in an internal intensive care unit.
    Voss R; Matthias FR; Borkowski G; Reitz D
    Br J Haematol; 1990 May; 75(1):99-105. PubMed ID: 1695855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A shift in balance between profibrinolytic and antifibrinolytic factors causes enhanced fibrinolysis in cirrhosis.
    Leebeek FW; Kluft C; Knot EA; de Maat MP; Wilson JH
    Gastroenterology; 1991 Nov; 101(5):1382-90. PubMed ID: 1718809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between age and plasma t-PA, PA-inhibitor, and PA activity.
    Hashimoto Y; Kobayashi A; Yamazaki N; Sugawara Y; Takada Y; Takada A
    Thromb Res; 1987 Jun; 46(5):625-33. PubMed ID: 3114907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinolysis during normal human pregnancy: complex inter-relationships between plasma levels of tissue plasminogen activator and inhibitors and the euglobulin clot lysis time.
    Wright JG; Cooper P; Astedt B; Lecander I; Wilde JT; Preston FE; Greaves M
    Br J Haematol; 1988 Jun; 69(2):253-8. PubMed ID: 3134043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dependence of fibrinolytic activity on the concentration of free rather than total tissue-type plasminogen activator in plasma after pharmacologic administration.
    Lucore CL; Fujii S; Sobel BE
    Circulation; 1989 Jun; 79(6):1204-13. PubMed ID: 2498004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal fibrinolysis in healthy male cigarette smokers: role of plasminogen activator inhibitors.
    Haire WD; Goldsmith JC; Rasmussen J
    Am J Hematol; 1989 May; 31(1):36-40. PubMed ID: 2495714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative changes in the plasmatic levels of tissue-type plasminogen activator and its fast-acting inhibitor--relationship to deep vein thrombosis and influence of prophylaxis.
    Páramo JA; Alfaro MJ; Rocha E
    Thromb Haemost; 1985 Oct; 54(3):713-6. PubMed ID: 3937269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residual plasminogen activator inhibitor activity after venous stasis as a criterion for hypofibrinolysis: a study in 83 patients with confirmed deep vein thrombosis.
    Nguyen G; Horellou MH; Kruithof EK; Conard J; Samama MM
    Blood; 1988 Aug; 72(2):601-5. PubMed ID: 3135860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinolytic capacity following stimulation with desmopressin acetate in patients with diabetes mellitus.
    Grant MB; Fitzgerald C; Guay C; Lottenberg R
    Metabolism; 1989 Sep; 38(9):901-7. PubMed ID: 2505017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of retinal detachment surgery on perioperative blood fibrinolysis.
    Malukiewicz-Wiśniewska G; Kotschy M; Kałuzny J
    Curr Eye Res; 1999 Aug; 19(2):123-30. PubMed ID: 10420181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of tissue-type plasminogen activator with plasma inhibitors and their pharmacologic implications.
    Lucore CL; Sobel BE
    Circulation; 1988 Mar; 77(3):660-9. PubMed ID: 2449299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.